Fatty acids and schizophrenia

Lipids

Volumn 31, Issue 3 SUPPL., 1996, Pages

  Laugharne, J D E ^a   Mellor, J E ^a   Peet, M ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL;

CONFERENCE PAPER; DIET SUPPLEMENTATION; ERYTHROCYTE MEMBRANE; FAT INTAKE; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; HUMAN; LIPID COMPOSITION; LIPID PEROXIDATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHOLIPID METABOLISM; SCHIZOPHRENIA;

CASE-CONTROL STUDIES; ERYTHROCYTE MEMBRANE; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; HUMANS; LIPID PEROXIDATION; SCHIZOPHRENIA;

EID: 0029867156     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02637070     Document Type: Article

References (28)

1. Murray, R.M. (1994) Neurodevelopmental Schizophrenia: Rediscovery of Dementia Praecox, Br. J. Psych. 165 (suppl. 25), 6-12.
2. Obi. F.O., and Nwanze, E.A.C. (1979) Fatty Acid Profiles in Mental Diseases, Journal of Neurological Sciences 43, 447-454.
3. Horrobin, D.F., Manku, M.S., Morse-Fisher, N., Vaddadi, K.S., Courtney, P. Glen, A.I.M., Glen, E., Spellman, M., and Bates, C. (1989) Essential Fatty Acids in Plasma Phospholipids in Schizophrenia, Biol. Psychiatry 25, 562-568.
4. Kaiya, H., Horrobin, D.F., Manku, M.S., and Morse-Fisher, N. (1991) Essential and Other Fatty Acids in Plasma from Schizophrenics and Normal Individuals from Japan, Biol. Psychiatry. 30, 357-362.
5. Bates, C., Horrobin, D.F., and Ellis, K. (1991) Fatty Acids in Plasma Phospholipids and Cholesterol Esters from Identical Twins Concordant and Discordant for Schizophrenia, Schizophr. Res. 6, 1-7.
6. Peet, M., Laugharne, J.D.E., Rangarajan, N., Horrobin, D.F., and Reynolds, G.P., Depleted Red Cell Membrane Essential Fatty Acids in Drug Treated Schizophrenic Patients, Journal of Psychiatric Research, in press.
7. Glen, A.I.M., Glen, E.M.T., Horrobin, D.F., Vaddadi, K.S., Spellman, M., Morse-Fisher, N., Ellis. K., and Skinner, F.S. (1994) A Red Cell Membrane Abnormality in a Subgroup of Schizophrenic Patients: Evidence for Two Diseases, Schizophr. Res. 12, 53-61.
8. Connor, W.E., Lin, D.S., and Neuringer, M. (1993) Is the Docosahexaenoic Acid (DHA) Content of Erythrocytes a Marker for the DHA Content of Brain Phospholipids? FASEB J. 7, A152.
9. Kovaleva, E.S., Orlov, O.N., Tsutsulkovskaia, M.I.A., Vladimirova, T.V., and Beliaev, B.S. (1989) Lipid Peroxidation Processes in Patients with Schizophrenia. Zhurnal Neuropatologit I Psikhiatrii 89, 108-110.
10. Phillips, M., Sabas, M., and Greenberg, J. (1993) Increased Pentane and Carbon Disulphide in the Breath of Patients with Schizophrenia, Journal of Clinical Pathology 46, 861-864.
11. Gattaz, W.F., Hubner, C.K., Nevalainen, T.J., Thuren, T., and Kinnunen, P.K. (1990) Increased Serum Phospholipase A2 Activity in Schizophrenia: A Replication Study. Biol. Psychiatry 28, 495-503.
12. Maras, A., Stendle, A., and Gattaz, W.F. (1994) Increased Platelet Phospholipase A2 Activity in Schizophrenics and Reduction After Neuroleptic Treatment (abstract), Schizophr. Res. 11, 123.
13. Chang, J., Musser, J.H., and McGregor, H. (1987) Phospholipase A2: Function and Pharmacological Regulation, Biochemical Pharmacology 36, 2429-2436.
14. Mahadik, S.P., Mukherjee, S., Correnti, E.E., and Scheffer, R. (1995) Elevated Levels of Lipid Peroxidation Products in Plasma of Drug-Naive Patients at the Onset of Psychosis (abstract). Schizophr. Res. 15, 66.
15. Buckman, T., Kling, A., Eiduson. S., Sutphin, M., and Steinberg. A. (1987) Glutathione Peroxidase and CT Scan Abnormalities in Schizophrenia, Biol. Psychiatry 22, 1349-1356.
16. Andreason, N.C., Ehrhardt, J.C., Swayze, V.W., Alliger, R.J., Yuh, W.T.C., Cohen, G., and Ziebell, S. (1990) Magnetic Resonance Imaging of the Brain in Schizophrenia, Arch. Gen. Psychiatry 47, 35-44.
17. Pettegrew J.W., Keshaven, M.S., Panchalingham, K., Strychor, M.P.H., Kaplan, D.B., Tretta, M.G., and Allen, M. (1991) Alterations in Brain High-Energy Phosphate and Membrane Phospholipid Metabolism in First Episode Drug-Naive Schizophrenics, Arch. Gen. Psychiatry 48, 563-568.
18. Stanley, J.A., Williamson, P.C., Drost, D.J., Carr, T.J., Rylett, R.J., Morrison-Stewart, S., and Thompson, R.T. (1994) Membrane Phospholipid Metabolism and Schizophrenia: An in vivo 31PMR Spectroscopy Study, Schizophr, Res. 13, 209-215.
19. 31Phosphorus Magnetic Resonance Spectroscopy of the Frontal and Parietal Lobes in Chronic Schizophrenia, Biol. Psychiatry 36, 503-510.
20. Christensen, O., and Christensen, E. (1988) Fat Consumption and Schizophrenia, Acta. Psychiatr. Scand. 78, 587-591.
21. Bourre, J.-M., Bonneil, M., Chaudiere, J., Clement, M., Dumont, O., Durand, G., Lafont, H., Nalbone, G., Pascal, G., and Piciotti, M. (1992) Structural and Functional Importance of Dietary Fatty Acids in the Nervous System, in Neurobiology of Essential Fatty Acids, (Bazan, N.G., Murphy, M.G., and Toffano, G., eds.) pp. 211-229, Plenum Press, New York.
22. Kinsella, J.E. (1990) Lipids, Membrane Receptors and Enzymes: Effects of Dietary Fatty Acids, J. Parenteral and Enteral Nutrition 14, 2005-2175.
23. Vaddadi, K.S. (1992) Use of Gammalinolenic Acid in the Treatment of Schizophrenia and Tardive Dyskinesia, Prostaglandins, Leukotrienes, EFAs. 46, 67-70.
24. Mellor, J.E., Laugharne, J.D.E., Peet, M., and Horrobin, D.F. (1994) Eicosapentanoic Acid and Schizophrenia (abstract), Neuropsychopharmacology 10, 256S.
25. Piomelli, D., Pilon, C., Giros, B., Sokoloff, P., Martres, M.P., and Schwanz, J-C. (1991) Dopamine Activation of the Arachidonic Acid Cascade as a Basis for D1/D2 Receptor Synergism, Nature 353, 164-167.
26. Barbour, B., Szatkowski, M., Ingledew, N., and Attwell, D. (1989) Arachidonic Acid Produces a Prolonged Inhibition of Glutamate Uptake into Glial Cells, Nature 342, 918-920.
27. Davidson, B.C., and Giangregorio, A. (1994) Exogenous Polyenoic Fatty Acids Modulation of Dopaminergic Neurotransmission in Cat and Rat (abstract), Neuropsychopharmacology 10, 17S.
28. Peet, M., Laugharne, J.D.E., Horrobin, D.F., and Reynolds, G.P. (1994) Arachidonic Acid: A Common Link in the Biology of Schizophrenia? Arch. Gen. Psychiatry 51, 665-666.